Last updated on February 2018

A Study of AEB1102 (Pegzilarginase) in Patients With Arginase I Deficiency

Brief description of study

The purpose of this study is to investigate the long-term safety, tolerability, immunogenicity, pharmacokinetics and pharmacodynamics of intravenous AEB1102 in patients who complete Study CAEB1102-101A.

Clinical Study Identifier: NCT03378531

Contact Investigators or Research Sites near you

Start Over

Roberto Zori, MD

University of Florida
Gainesville, FL United States
  Connect »